Skip to main content

Annals of Surgical Oncology

Ausgabe 3/2020

Inhalt (63 Artikel)

Doing Our Part to Mitigate the Opioid Crisis

  • Breast Oncology

Crystal Fancher, Alicia M. Terando

Can Prognosis Be Modified in Pancreatic Cancer?

  • Pancreatic Tumors

Motaz Qadan, Carlos Fernandez-del Castillo

Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01)

  • Health Services Research and Global Oncology

T. J. Stankowski-Drengler, J. R. Schumacher, B. Hanlon, D. Livingston-Rosanoff, K. Van de Walle, C. C. Greenberg, L. G. Wilke, H. B. Neuman

Multidisciplinary Teams Improve Gastric Cancer Treatment Efficiency at a Large Safety Net Hospital

  • Health Services Research and Global Oncology

Michelle Ju, Sam C. Wang, Samira Syed, Deepak Agrawal, Matthew R. Porembka

Clinicopathologic Characteristics of Oligometastases from Esophageal Cancer and Long-Term Outcomes of Resection

  • Thoracic Oncology

Yu Ohkura, Junichi Shindoh, Masaki Ueno, Toshiro Iizuka, Harushi Udagawa

Utility of Radiation After Neoadjuvant Chemotherapy for Surgically Resectable Esophageal Cancer

  • Thoracic Oncology

Francis I. Macedo, Jose Wilson Mesquita-Neto, Kristin N. Kelly, Basem Azab, Danny Yakoub, Nipun B. Merchant, Alan S. Livingstone, Dido Franceschi

Is There a Role for Surgery in Patients with Neuroendocrine Tumors of the Esophagus? A Contemporary View from the NCDB

  • Thoracic Oncology

Suna Erdem, Esther Troxler, René Warschkow, Catherine Tsai, Babatunde Yerokun, Bruno Schmied, Christoph Stettler, Dan G. Blazer III, Matthew Hartwig, Mathias Worni, Beat Gloor

Tooth Loss Predicts Long-Term Prognosis of Esophageal Cancer After Esophagectomy

  • Thoracic Oncology

Susumu Miura, Tetsu Nakamura, Takumi Hasegawa, Yukiko Miura, Gosuke Takiguchi, Naoki Urakawa, Hiroshi Hasegawa, Masashi Yamamoto, Shingo Kanaji, Yoshiko Matsuda, Kimihiro Yamashita, Takeru Matsuda, Taro Oshikiri, Satoshi Suzuki, Masaya Akashi, Yoshihiro Kakeji

Impact of Lymphadenectomy on Survival After Unimodality Transthoracic Esophagectomy for Adenocarcinoma of Esophagus

  • Thoracic Oncology

A. W. Phillips, K. Hardy, M. Navidi, S. K. Kamarajah, A. Madhavan, A. Immanuel, S. M. Griffin

ASO Author Reflections: Lymphadenectomy in Esophagectomy: Why Bother?

  • ASO Author Reflections

Alexander W. Phillips, Sivesh K. Kamarajah

Propensity-Matched Analysis Comparing Survival After Sublobar Resection and Lobectomy for cT1N0 Lung Adenocarcinoma

  • Thoracic Oncology

Xu-Heng Chiang, Hsao-Hsun Hsu, Min-Shu Hsieh, Chia-Hong Chang, Tung-Ming Tsai, Hsien-Chi Liao, Kuan-Chuan Tsou, Mong-Wei Lin, Jin-Shing Chen

Surgical and Surgeon-Related Factors Related to Long-Term Survival in Esophageal Cancer: A Review

  • Open Access
  • Thoracic Oncology

Sheraz R. Markar, Jesper Lagergren

The Landmark Series: Axillary Management in Breast Cancer

  • Breast Oncology

Carla S. Fisher, Julie A. Margenthaler, Kelly K. Hunt, Theresa Schwartz

Opioid Use after Breast-Conserving Surgery: Prospective Evaluation of Risk Factors for High Opioid Use

  • Breast Oncology

Ko Un Park, Kristin Kyrish, Min Yi, Isabelle Bedrosian, Abigail S. Caudle, Henry M. Kuerer, Kelly K. Hunt, Makesha V. Miggins, Sarah M. DeSnyder

The Tyrer–Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS

  • Breast Oncology

Monica G. Valero, Emily C. Zabor, Anna Park, Elizabeth Gilbert, Ashely Newman, Tari A. King, Melissa L. Pilewskie

ASO Author Reflections: Breast Cancer Risk Assessment in Women with LCIS—More Work Is Needed

  • ASO Author Reflections

Monica G. Valero, Tari A. King, Melissa L. Pilewskie

Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy

  • Breast Oncology

Nicole Christian, Emily C. Zabor, Michael Cassidy, Jessica Flynn, Monica Morrow, Mary L. Gemignani

Local Failure After Accelerated Partial Breast Irradiation with Intraoperative Radiotherapy with Electrons: An Insight into Management and Outcome from an Italian Multicentric Study

  • Breast Oncology

Maria Cristina Leonardi, Luigi Tomio, Davide Radice, Silvia Takanen, Elisabetta Bonzano, Marina Alessandro, Antonella Ciabattoni, Giovanni Battista Ivaldi, Vincenzo Bagnardi, Ombretta Alessandro, Claudia Maria Francia, Cristiana Fodor, Eleonora Miglietta, Paolo Veronesi, Viviana Enrica Galimberti, Roberto Orecchia, Luca Tagliaferri, Cristiana Vidali, Mariangela Massaccesi, Marina Guenzi, Barbara Alicja Jereczek-Fossa

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer

  • Open Access
  • Breast Oncology

Hatem Soliman, Susanne Wagner, Darl D. Flake II, Mark Robson, Lee Schwartzberg, Priyanka Sharma, Anthony Magliocco, Ralf Kronenwett, Johnathan M. Lancaster, Jerry S. Lanchbury, Alexander Gutin, William Gradishar

Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin

  • Peritoneal Surface Malignancy

Omeed Moaven, Konstantinos I. Votanopoulos, Perry Shen, Paul Mansfield, David L. Bartlett, Greg Russell, Richard McQuellon, John H. Stewart, Edward A. Levine

ASO Author Reflections: Patient-Reported Outcomes of Mucinous Appendiceal Cancer Improve with Oxaliplatin HIPEC

  • ASO Author Reflections

Omeed Moaven, Kathleen C. Perry, Konstantinos I. Votanopoulos, Perry Shen, Edward A. Levine

Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter?

  • Peritoneal Surface Malignancy

Jason T. Wiseman, Charles Kimbrough, Eliza W. Beal, Mohammad Y. Zaidi, Charles A. Staley, Travis Grotz, Jennifer Leiting, Keith Fournier, Andrew J. Lee, Sean Dineen, Benjamin Powers, Jula Veerapong, Joel M. Baumgartner, Callisia Clarke, Sameer H. Patel, Vikrom Dhar, Ryan J. Hendrix, Laura Lambert, Daniel E. Abbott, Courtney Pokrzywa, Mustafa Raoof, Byrne Lee, Nadege Fackche, Jonathan Greer, Timothy M. Pawlik, Sherif Abdel-Misih, Jordan M. Cloyd

The Suggestion of Revised Criteria for Endoscopic Resection of Differentiated-Type Submucosal Gastric Cancer

  • Peritoneal Surface Malignancy

Dae Won Ma, Seok Joo Lee, Myeong-Cherl Kook, Do Youn Park, Sangjeong Ahn, Keun Won Ryu, Il Ju Choi, Sung Hoon Noh, Hyunki Kim, Yong Chan Lee, Jie-Hyun Kim

Long-Term Survival after Minimally Invasive Versus Open Gastrectomy for Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of Patients in the United States and China

  • Gastrointestinal Oncology

Jun Lu, Changhwan Yoon, Binbin Xu, Jianwei Xie, Ping Li, Chaohui Zheng, Changming Huang, Sam S. Yoon

Feasibility and Safety of Early Oral Intake and Discharge After Total or Proximal Gastrectomy: An Analysis of Consecutive Cases Without Exclusion Criteria

  • Gastrointestinal Oncology

Masatoshi Nakagawa, Masanori Tokunaga, Tomoki Aburatani, Yuya Sato, Takatoshi Matsuyama, Yasuaki Nakajima, Yusuke Kinugasa

Technique for Robotic Ivor Lewis Esophagectomy with 6-cm Linear Stapled Side-to-Side Anastomosis

  • Gastrointestinal Oncology

June S. Peng, Steven J. Nurkin, Steven N. Hochwald, Moshim Kukar

Utilization of Adjuvant Radiotherapy for Resected Colon Cancer and Its Effect on Outcome

  • Colorectal Cancer

Rodney E. Wegner, Stephen Abel, Dulabh Monga, Moses Raj, Gene Finley, Stanislav Nosik, James McCormick, Alexander V. Kirichenko

Perioperative Blood Transfusion is Associated with Postoperative Systemic Inflammatory Response and Poorer Outcomes Following Surgery for Colorectal Cancer

  • Open Access
  • Colorectal Cancer

Stephen T. McSorley, Alexander Tham, Ross D. Dolan, Colin W. Steele, Jason Ramsingh, Campbell Roxburgh, Paul G. Horgan, Donald C. McMillan

Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer

  • Colorectal Cancer

Shinsuke Suzuki, Takashi Akiyoshi, Koji Oba, Fuhito Otsuka, Tetsuro Tominaga, Toshiya Nagasaki, Yosuke Fukunaga, Masashi Ueno

Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors

  • Endocrine Tumors

Ian W. Folkert, Andrew J. Sinnamon, Seth J. Concors, Bonita J. Bennett, Douglas L. Fraker, Najjia N. Mahmoud, David C. Metz, Kristen M. Stashek, Robert E. Roses

Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines

  • Hepatobiliary Tumors

Diamantis I. Tsilimigras, Rittal Mehta, Dimitrios Moris, Kota Sahara, Fabio Bagante, Anghela Z. Paredes, Ayesha Farooq, Francesca Ratti, Hugo P. Marques, Silvia Silva, Olivier Soubrane, Vincent Lam, George A. Poultsides, Irinel Popescu, Razvan Grigorie, Sorin Alexandrescu, Guillaume Martel, Aklile Workneh, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik

Fong’s Score in the Era of Modern Perioperative Chemotherapy for Metastatic Colorectal Cancer: A Post Hoc Analysis of the GERCOR-MIROX Phase III Trial

  • Hepatobiliary Tumors

Samira Makhloufi, Anthony Turpin, Mehdi el Amrani, Thierry André, Stéphanie Truant, Jean-Baptiste Bachet, Dewi Vernerey, Mohamed Hebbar

Clinical Implications of Naples Prognostic Score in Patients with Resected Pancreatic Cancer

  • Pancreatic Tumors

Nobuhiko Nakagawa, Suguru Yamada, Fuminori Sonohara, Hideki Takami, Masamichi Hayashi, Mitsuro Kanda, Daisuke Kobayashi, Chie Tanaka, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera

Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer

  • Pancreatic Tumors

Pranav Murthy, Mazen S. Zenati, Amr I. Al Abbas, Caroline J. Rieser, Nathan Bahary, Michael T. Lotze, Herbert J. Zeh III, Amer H. Zureikat, Brian A. Boone

National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection

  • Pancreatic Tumors

Ryan J. Ellis, Jessie W. Ho, Cary Jo R. Schlick, Ryan P. Merkow, David J. Bentrem, Karl Y. Bilimoria, Anthony D. Yang

High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer

  • Translational Research and Biomarkers

Kei Hagiwara, Norifumi Harimoto, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Dorgormaa Gantumur, Takahiro Yamanaka, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Hiroshi Tanaka, Akira Watanabe, Norio Kubo, Kenichiro Araki, Yasuo Hosouchi, Ken Shirabe

High Stromal TGFBI in Lung Cancer and Intratumoral CD8-Positive T Cells were Associated with Poor Prognosis and Therapeutic Resistance to Immune Checkpoint Inhibitors

  • Translational Research and Biomarkers

Nobuhiro Nakazawa, Takehiko Yokobori, Kyoichi Kaira, Andrei Turtoi, Seded Baatar, Navchaa Gombodorj, Tadashi Handa, Mariko Tsukagoshi, Yasunari Ubukata, Akiharu Kimura, Norimichi Kogure, Kyoichi Ogata, Toshitaka Maeno, Makoto Sohda, Toshiki Yajima, Kimihiro Shimizu, Akira Mogi, Hiroyuki Kuwano, Hiroshi Saeki, Ken Shirabe

ASO Author Reflections: High Stromal TGFBI is a Useful Predictive Marker for Nivolumab in Non-small Cell Lung Cancer

  • ASO Author Reflections

Nobuhiro Nakazawa, Takehiko Yokobori, Andrei Turtoi, Ken Shirabe

Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary Component

  • Translational Research and Biomarkers

Naoto Kishi, Masaoki Ito, Yoshihiro Miyata, Akinori Kanai, Yoshinori Handa, Yasuhiro Tsutani, Kei Kushitani, Yukio Takeshima, Morihito Okada

Indication for Sublobar Resection in cT1N0 Lung Adenocarcinoma is Contentious

  • Thoracic Oncology

Xu-Heng Chiang, Mong-Wei Lin, Jin-Shing Chen

Neu im Fachgebiet Chirurgie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Appendizitis und Darminfarkt durch Blinddarm-Lipom

Eigentlich sind Lipome recht harmlos. Im Zäkum können sie jedoch erhebliche Komplikationen mit Darminfarkt und Appendizitis verursachen.

Gluteuslappen nach Rektumkarzinom-Op. schützt vor Abszessen

Die Wunddeckung mit einem autologen Rotationslappen nach Entfernung eines Rektumkarzinoms konnte in einer randomisierten Studie gegenüber dem primären Wundverschluss vor allem in einer Hinsicht punkten: Sie führte deutlich seltener zu präsakralen Abszessen.

Webinar

MedTalk Leitlinie KOMPAKT: S3-Leitline zu peripheren Nervenverletzungen

  • Webinar | 10.02.2025 | 13:00

Über den Weg zur finalen Fassung der S3-Leitlinie "Versorgung peripherer Nervenverletzungen" spricht Prof. Dr. Leila Harhaus-Wähner im MedTalk Leitlinie KOMPAKT. In dem kurzen Video geht es darum, was sich im Vergleich zur vorigen Fassung der Leitlinie geändert hat, welche Aspekte für die tägliche Praxis besonders wichtig sind und was jeder gemäß Leitlinie nun anders oder besser machen sollte.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.